| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.021 | 0.9 |